FATE
#3315
Fate Therapeutics, Inc. - Common Stock
2.5 4 USD
-0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.17%
Variación mensual
+9.01%
Variación en los últimos 6 meses
+75.17%
Cambio anual
+135.19%
Cierres anteriores
2.5 7
Open
2.5 4
Mínimo
2.5 4
Máximo
2.5 4
Volumen
48
Financials
- Market Capitalization 304.34 M
- Employee 161
- Founded 2007
- CEO Scott Wolchko
- Website www.fatetherapeutics.com
- Headquarter California, United States
- FIGI BBG000QP35H2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.85
Relación precio/flujo de caja
17.56
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3267 |  IRD Opus Genetics, Inc. - Common Stock | 3.85 USD | +1.32% | -7.45% | +11.59% | +3.49% | 320.30 M USD | ||
| 3309 |  OBIO Orchestra BioMed Holdings, Inc. - Ordinary Shares | 5.11 USD | -2.85% | -6.58% | +32.73% | +87.87% | 307.14 M USD | ||
| 3321 |  RNAC Cartesian Therapeutics, Inc. - Common Stock | 9.97 USD | -2.16% | -3.67% | +29.82% | +8.84% | 301.65 M USD | ||
| 3325 |  TTRX Turn Therapeutics Inc. - Common Stock | 10.11 USD | +4.98% | +4.88% | +32.16% | +1.10% | 301.16 M USD |